Glioblastoma multiforme: Diagnosis, treatment, and invasion

被引:13
作者
Li, Jiawei [1 ,2 ]
Feng, Lili [3 ,4 ]
Lu, Yingmei [1 ,5 ]
机构
[1] Nanjing Med Univ, Sch Basic Med Sci, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Clin Med Coll 1, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Drug Target & Drug Discovery Ctr, Sch Pharm, Key Lab Cardiovasc & Cerebrovascular Med, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Drug Target & Drug Discovery Ctr, Sch Pharm, Key Lab Cardiovasc & Cerebrovascular Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Sch Basic Med Sci, Dept Physiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
来源
JOURNAL OF BIOMEDICAL RESEARCH | 2023年 / 37卷 / 01期
基金
中国国家自然科学基金;
关键词
glioblastoma multiforme; diagnosis; treatment; patterns of invasion; invasion mechanism; P53; CANCER; METASTASIS; THERAPY; GLIOMA; CELLS; EGFR;
D O I
10.7555/JBR.36.20220156
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glioblastoma multiforme (GBM) is an essentially incurable brain tumor, which has been explored for approximately a century. Nowadays, surgical resection, chemotherapy, and radiation therapy are still the standardized therapeutic options. However, due to the intrinsic invasion and metastasis features and the resistance to chemotherapy, the survival rate of glioblastoma patients remains unsatisfactory. To improve the current situation, much more research is needed to provide comprehensive knowledge of GBM. In this review, we summarize the latest updates on GBM treatment and invasion. Firstly, we review the traditional and emerging therapies that have been used for GBM treatment. Given the limited efficiency of these therapies, we further discuss the role of invasion in GBM recurrence and progression, and present current research progress on the mode and mechanisms of GBM invasion.
引用
收藏
页码:47 / 58
页数:13
相关论文
共 87 条
[1]  
Abadi Banafshe, 2021, Hematol Oncol Stem Cell Ther, V14, P1, DOI 10.1016/j.hemonc.2020.08.001
[2]   Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion [J].
Alieva, Maria ;
Leidgens, Verena ;
Riemenschneider, Markus J. ;
Klein, Christoph A. ;
Hau, Peter ;
van Rheenen, Jacco .
SCIENTIFIC REPORTS, 2019, 9 (1)
[3]   Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies [J].
An, Zhenyi ;
Aksoy, Ozlem ;
Zheng, Tina ;
Fan, Qi-Wen ;
Weiss, William A. .
ONCOGENE, 2018, 37 (12) :1561-1575
[4]   Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review [J].
Anjum, Komal ;
Shagufta, Bibi Ibtesam ;
Abbas, Syed Qamar ;
Patel, Seema ;
Khan, Ishrat ;
Shah, Sayed Asmat Ali ;
Akhter, Najeeb ;
ul Hassan, Syed Shams .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 92 :681-689
[5]  
[Anonymous], 2012, LIVERTOX CLIN RES IN
[6]  
[Anonymous], 2020, CANCERS, V12, P242
[7]   Radiation guidelines for gliomas [J].
Antoni, D. ;
Feuvret, L. ;
Biau, J. ;
Robert, C. ;
Mazeron, J-J ;
Noel, G. .
CANCER RADIOTHERAPIE, 2022, 26 (1-2) :116-128
[8]  
Bagherian A, 2021, FOOD FUNCT, V12, P10926, DOI [10.1039/d1fo01611c, 10.1039/D1FO01611C]
[9]  
Barani IJ, 2015, CANCER TREAT RES, V163, P49, DOI 10.1007/978-3-319-12048-5_4
[10]   Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells [J].
Blandin, Anne-Florence ;
Da Silva, Elisabete Cruz ;
Mercier, Marie-Cecile ;
Glushonkov, Oleksandr ;
Didier, Pascal ;
Dedieu, Stephane ;
Schneider, Cristophe ;
Devy, Jessica ;
Etienne-Selloum, Nelly ;
Dontenwill, Monique ;
Choulier, Laurence ;
Lehmann, Maxime .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (06) :2949-2962